Fluidigm Corp
Change company Symbol lookup
Select an option...
FLDM Fluidigm Corp
TELL Tellurian Inc
PFE Pfizer Inc
AGNC Agnc Investment Corp
AAPL Apple Inc
GRTYA Guaranty Corp
SATS EchoStar Corp
$DJI Dow Jones Industrials
TIKK Tel-Instrument Electronics Corp
TEAM Atlassian Corporation PLC
Go

Health Care : Life Sciences Tools & Services | Small Cap Blend
Company profile

Fluidigm Corporation creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company's core microfluidics and mass cytometry technologies. The Company operates in the development, manufacturing and commercialization of life science tools for the life science and Ag-Bio industries segment. Its products include preparatory instruments, preparatory analytical instruments, analytical instruments, integrated fluidic circuits (IFCs), and assays and reagents. Its preparatory instruments include C1 Single-Cell Auto Prep System, Access Array System, Juno System and IFCs, and Callisto System and IFC. Its analytical instruments include Biomark HD System, EP1 System and Helios/CyTOF 2 System. Its assays and reagents include Delta Gene and SNP Type Assays, and Access Array Target-Specific Primers and Targeted Sequencing Prep Primers.

Price
Delayed
$6.11
Day's Change
0.05 (0.83%)
Bid
--
Ask
--
B/A Size
--
Day's High
6.29
Day's Low
5.99
Volume
(Light)

Today's volume of 866,718 shares is on pace to be much lighter than FLDM's 10-day average volume of 1,954,484 shares.

866,718

FLDM INVESTOR DEADLINE: Bernstein Liebhard Reminds Investors of the Lead Plaintiff Deadline in a Securities Fraud Class Action Against Fluidigm Corporation

9:47 am ET October 27, 2020 (PR Newswire) Print

Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action that has been filed on behalf of investors that purchased or acquired the securities of Fluidigm Corporation ("Fluidigm" or the "Company") (NASDAQ: FLDM) between February 7, 2019, and November 5, 2019(the "Class Period"). The lawsuit filed in the United States District Court for the Northern District of California alleges violations of the Securities Exchange Act of 1934.

https://mma.prnewswire.com/media/616919/Bernstein_Liebhard_LLP_Logo.jpg

If you purchased Fluidigm securities, and/or would like to discuss your legal rights and options please visit FLDM Shareholder Class Action Lawsuit or contact Matthew E. Guarnero toll free at (877) 779-1414 or MGuarnero@bernlieb.com.

The complaint alleges that throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) that Fluidigm was experiencing longer sales cycles; (2) that, as a result, Fluidigm's revenue was reasonably likely to decline; and (3) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

On November 5, 2019, after the market closed, Fluidigm reported that third quarter 2019 revenue declined 8.5% year-over-year primarily due to mass cytometry instrument sales. On this news, the Company's share price fell $2.60, or 51% to close at $2.51 per share on November 6, 2019.

If you wish to serve as lead plaintiff, you must move the Court no later than November 20, 2020. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Your ability to share in any recovery doesn't require that you serve as lead plaintiff. If you choose to take no action, you may remain an absent class member.

If you purchased Fluidigm securities, and/or would like to discuss your legal rights and options please visit https://www.bernlieb.com/cases/fluidigmcorporation-fldm-shareholder-class-action-lawsuit-stock-fraud-312/apply/ contact Matthew E. Guarnero toll free at (877) 779-1414 or MGuarnero@bernlieb.com.

Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of lawsuits and class actions, the Firm has been named to The National Law Journal's "Plaintiffs' Hot List" thirteen times and listed in The Legal 500 for ten consecutive years.

ATTORNEY ADVERTISING. (C) 2020 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Michael S. Bigin. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information

Matthew E. GuarneroBernstein Liebhard LLPhttps://www.bernlieb.com(877) 779-1414MGuarnero@bernlieb.com

https://c212.net/c/img/favicon.png?sn=DC42951&sd=2020-10-27

View original content to download multimedia:http://www.prnewswire.com/news-releases/fldm-investor-deadline-bernstein-liebhard-reminds-investors-of-the-lead-plaintiff-deadline-in-a-securities-fraud-class-action-against-fluidigm-corporation-301149356.html

SOURCE Bernstein Liebhard LLP

https://rt.prnewswire.com/rt.gif?NewsItemId=DC42951&Transmission_Id=202010270947PR_NEWS_USPR_____DC42951&DateId=20201027

comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.